Secukinumab induced Behçet’s syndrome: a report of two cases

Secukinumab is a human monoclonal antibody against IL-17A that has been shown to be effective in psoriasis, psoriatic arthritis and ankylosing spondylitis (AS). On the other hand, in randomized controlled trials among patients with Crohn’s disease (CD) and uveitis due to Behçet’s syndrome (BS) treat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oxf Med Case Reports
Hauptverfasser: Dincses, Elif, Yurttas, Berna, Esatoglu, Sinem N, Melikoglu, Melike, Hamuryudan, Vedat, Seyahi, Emire
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2019
Schlagworte:
Case Report
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6544425/
https://ncbi.nlm.nih.gov/pubmed/31198577
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/omcr/omz041
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge